Defibrillators Market - Trends Forecast Till 2028

Defibrillator Market, by Product Type (Implantable Cardioverter Defibrillator and External Defibrillator), Patient Type (Adult, Paediatric), End Users, and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: December, 2021

Base Year Estimate: 2020

Report ID: D-HC-DM-1024

Format:  

Number of Pages: 348

Domain: Healthcare

Defibrillators Market – Trends Forecast Till 2028

The global defibrillators market is projected to reach USD 11.4 billion in 2021, at a CAGR of 10.7% from 2021-2028.

Defibrillators are devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse.

The rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators are some of the factors that have supported long-term expansion for Defibrillators Market.

Defibrillators Market Research Report

The Asia Pacific region is expected to register the highest growth during the forecast period. The Asia Pacific is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific, including Malaysia, Taiwan, Singapore, and New Zealand.

Defibrillators Market is segmented into type, patients’ type, end user and region.

On the basis of Type

  • Implantable cardioverter defibrillators
  • Transvenous implantable cardioverter defibrillators
  • Subcutaneous implantable cardioverter defibrillators
  • External defibrillators
  • Manual & semi-automated external defibrillators
  • Fully automated external defibrillators
  • Wearable cardioverter defibrillators

On the basis of Patient’s Type  

  • Adults
  • Paediatrics

On the basis of End-User  

  • Implantable cardioverter defibrillators
  • Transvenous implantable cardioverter defibrillators
  • Subcutaneous implantable cardioverter defibrillators
  • External defibrillators
  • Manual & semi-automated external defibrillators
  • Fully automated external defibrillators
  • Wearable cardioverter defibrillators

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Defibrillators Market Primary Respondent

 

Key Players

  • Asahi Kasei Corporation
  • Stryker Corporation
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Philips Healthcare
  • LivaNova PLC
  • Medtronic plc
  • Cardiac Science Corporation
  • Nihon Kohden Corporation
  • St. Jude Medical, Inc.

Recent Developments

  • In July 2020, Abbott received FDA approval for its next generation ICDs and CRT-Ds under the brand name Gallant.
  • In June 2020, Koninklijke Philips received FDA pre-market approval for Heart Start FR3 and Heart Start FRX AED.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Defibrillators Market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 11.4 billion

Growth Rate

CAGR of 10.7% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year

2020

Units Considered

Revenue in USD billion and CAGR from 2021 to 2028

Report Segmentation

type, patients’ type, end user and region.

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.

Available Customization

In addition to the market data for Defibrillators Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.